跳至主要内容
临床试验/CTRI/2015/05/005769
CTRI/2015/05/005769已完成未知

An Observational, Cross sectional Study to assess the prevalence of chronic kidney disease in Type 2 Diabetes Patients in India - START- India

AstraZeneca Pharma India Ltd0 个研究点目标入组 3,000 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
3,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Known cases of T2DM.
  • Male and female patients aged 18 years and above
  • Must provide written Informed consent.

排除标准

  • Patients with known type-1 diabetes.
  • Patients with any form of acute kidney injury based on investigatorâ??s discretion.
  • Patients on maintenance dialysis or known renal transplant patients.
  • Patients with symptomatic Urinary Tract Infection (UTI) or with history of hematuria.

研究者

相似试验